Overview
OrbiMed is a global healthcare investment firm founded in New York City in 1989[8]. The firm manages approximately $20 billion in assets under management[1][6] and invests across biopharmaceuticals, medical devices, digital health, diagnostics and healthcare services, from early-stage private companies to large multinationals[1]. OrbiMed operates 12 global offices[6], including its headquarters at 601 Lexington Avenue in New York[3], as well as locations in San Francisco, Shanghai, Herzliya, Hong Kong and London[9]. The firm's team comprises over 150 scientific, medical, investment and other professionals[7]. As of its public disclosures, OrbiMed reports more than 500 portfolio companies and over 130 venture-backed initial public offerings[6]. Portfolio companies have included ADARx Pharmaceuticals, Treeline Biosciences, Mirador Therapeutics, Insmed Incorporated, Avenzo Therapeutics and Perfuse Therapeutics[10].
Org chart
Alumni
Investments
TytoCare
A healthtech company that provides AI-powered remote physical examination technology using FDA-cleared medical devices for clinical-grade virtual care
Traction
- OrbiMed reports $20 billion in assets under management across 12 global offices, more than 500 portfolio companies and 130+ venture-backed IPOs.[6]
Customers
- OrbiMed highlights portfolio companies including ADARx Pharmaceuticals, Treeline Biosciences, Mirador Therapeutics, Insmed Incorporated, Avenzo Therapeutics and Perfuse Therapeutics.[10]
NYC headquarters
- The company's own site places it in New York: New York address listed first under 'Global Locations': 601 Lexington Avenue (at 53rd Street), 54th Floor New York, NY 10022-4629. Listed as.[3]
- OrbiMed was founded in New York City in 1989 and has since added offices in San Francisco (2007), Shanghai (2007), Herzliya, Israel (2010), Hong Kong (2017) and London (2023).[9]
Team size
- OrbiMed describes "our team of over 150 distinguished scientific, medical, investment, and other professionals".[7]
Something wrong or missing? Send an update. Fixed within 24 hours.